Similarly, a neuronal miRNA-sensitive, EGFR-targeted oncolytic herpes simplex virus (oHSV) equipped with an MMP-9 transgene demonstrated improved intratumoral spread, oncolysis, and survival rates in a glioblastoma xenograft model (65). The gene discussed is MMP9; the disease is glioblastoma.